The Quiet Return: A Veteran Leader’s High-Stakes Bet on Dermatology’s Future

OTTAWA, Ontario – June 29, 2026 – The Canadian Dermatology Association (CDA) has announced the return of Dr. Mariusz Sapijaszko to its presidency, a role he previously held from 2016 to 2017. While leadership transitions are routine, this one is anything but. It signals a strategic deployment of a veteran hand to navigate the specialty through what is arguably its most turbulent period in a generation. The landscape of Canadian healthcare has shifted dramatically since his last tenure, and his re-election is a clear acknowledgment of the profound challenges that lie ahead.

Dr. Sapijaszko, an Edmonton-based dermatologist with extensive experience in skin cancer and surgical dermatology, steps into the role with a vision that is both ambitious and pragmatic. His focus is on reinforcing the value of dermatology, ensuring specialists maintain leadership in a rapidly evolving healthcare model, and advocating for patient access. “Every patient deserves to be seen by a Canadian dermatologist when they have skin, hair, or nail concerns. It is our duty to strive towards this goal and elevate dermatologic care in Canada,” Dr. Sapijaszko stated upon his appointment. This statement is not just a mission; it is a declaration of intent in a system where such access is increasingly a privilege rather than a guarantee.

A System Under Strain: The Anatomy of Canada's Dermatology Crisis

To understand the strategic rationale behind Dr. Sapijaszko’s return, one must first grasp the depth of the crisis facing his specialty. For years, the CDA and patient advocates have sounded the alarm over a critical and worsening shortage of dermatologists. With just over 800 certified specialists serving a nation of 40 million, the association itself estimates a current deficit of 465 dermatologists. This is not an abstract number; it translates into tangible human suffering.

Across the country, patients are facing staggering wait times for essential care, with averages of five months and, in some regions, delays stretching into years. For someone with a suspicious mole, this delay can be the difference between a simple excision and a life-threatening metastatic melanoma. For those suffering from chronic, debilitating conditions like severe psoriasis or eczema, the prolonged wait means enduring unnecessary pain, discomfort, and significant mental health tolls. The system is failing to meet its most basic obligations.

Compounding the shortage is a growing schism between medical and cosmetic dermatology. While patients wait for critical cancer screenings, appointments for privately paid cosmetic procedures are often available within days. Some healthcare analysts point to an “exodus from public medicine” as a factor, where outdated provincial billing for complex medical dermatology makes the economics of private cosmetic work far more attractive. This creates a two-tiered system by default, where access is dictated not by medical need but by the ability to pay for services outside the public system, undermining the very principles of Canadian healthcare.

Redefining the Front Line: The Inevitable Shift to Team-Based Care

The central strategic challenge that Dr. Sapijaszko and the CDA must confront is the government-endorsed shift toward a “team-based care environment.” Faced with systemic workforce shortages and ballooning costs, policymakers are betting on a model where tasks are distributed among a wider range of healthcare professionals. This isn't a distant concept; it's an imminent reality. A pivotal federal policy change, effective April 1, 2026, expands the Canada Health Act’s interpretation to cover “medically necessary” services provided by non-physician professionals like nurse practitioners and physician assistants under provincial health plans.

For dermatology, this presents both an opportunity and a profound threat. The opportunity lies in leveraging a broader team to improve efficiency and increase patient access, allowing dermatologists to focus on the most complex cases. The threat is the potential dilution of specialist expertise and a degradation in the quality of care if not managed correctly. The CDA’s strategy, therefore, is not to resist this tide but to steer it. The association is championing a principles-based approach where the dermatologist remains the “team leader or captain,” establishing protocols, providing oversight, and ensuring the quality of care delivered by the entire team.

This is a battle for control over the definition of expertise. By positioning the dermatologist as the central node in a collaborative network, the CDA aims to protect the specialty’s essential role while adapting to the new healthcare paradigm. It’s a delicate balancing act: embrace the team to solve the access crisis, but fiercely guard the standards that define specialist-led care.

A Blueprint for Influence: The CDA’s Strategic Response

Dr. Sapijaszko’s vision is, in effect, a blueprint for how the CDA will exert its influence in this new environment. His commitment to “enhance the value of CDA membership by delivering meaningful programs and services” is about equipping dermatologists with the tools they need to navigate this shift. This includes practical guides on how to structure and manage a team-based practice, advocacy for fair compensation models that reflect the complexity of modern dermatological care, and support for technologies like teledermatology to bridge geographic divides.

The CDA’s advocacy platform, “More than Skin Deep,” lays out a multi-pronged strategy that aligns perfectly with this vision. It calls for increased training spots to address the workforce shortage, innovative investments in specialty care, and public education campaigns to underscore the critical importance of skin health. This public-facing advocacy serves a dual purpose: it builds political capital to pressure governments for funding and policy changes, and it reinforces the message that patient access to a qualified dermatologist is non-negotiable.

Dr. Sapijaszko’s return to the presidency brings a leader with a deep understanding of these complex flows of influence. His focus on collaboration, member support, and unwavering patient advocacy is a calculated response to the forces reshaping Canadian healthcare. The path ahead involves navigating the intricate politics of provincial and federal health systems while fundamentally re-engineering how dermatological care is delivered at the clinic level. The success of this strategy will not only determine the future of the profession but will directly impact the health and well-being of millions of Canadians.